Tiny implant could spark natural erections after prostate removal

NCT ID NCT06968494

Recruiting now Disease control Sponsor: Comphya Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a new implantable device that stimulates nerves to help men recover natural erections after prostate cancer surgery. Twenty men aged 30-75 will receive the device during their prostate removal and be followed for 6 months. The main goals are to check if the device is safe and if it helps restore erectile function compared to a control group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: implantable nerve-stimulating device
What this could lead to: If it works, this device could help men regain natural erectile function after prostate removal, reducing the need for pills or injections.
What could go wrong: This is a very early, small trial with only 20 participants. The device requires surgery to implant, and it may not work for everyone or could cause side effects like pain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY

Contacts and locations

Locations

Johns Hopkins Hospital
RECRUITING

Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.